| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |